27 jun: IWC lancerer Big Pilot special edition i anledning af EM i fodbol..
28 jun: Når lav risiko giver højt afkast
27-06-2012 16:10:00

Xstrata: Retention Awards For All Recipients Will Be Paid Entirely In Shares In Combined Group

Relateret indhold

LONDON-- Xstrata PLC (XTA.LN), a mining company, said Wednesday regarding the merger with Glencore International (GLEN.LN) that retention awards for all recipients will be paid entirely in shares in the Combined Group, further aligning management's interests with shareholders

MAIN FACTS:

-100% of retention awards for Xstrata Executive Directors and the other Executive Committee members will be subject to performance criteria based on realising additional cost savings as a result of the Merger in the two years following the effective date.

-For Xstrata's senior management, excluding the Executive Directors and six other Executive Committee members, awards will be paid in equal tranches at the first and second anniversaries of the closing of the transaction.

-The number of shares in the Combined Group to be awarded under the amended retention arrangements will be determined by reference to the average of the closing prices of Xstrata shares over the seven dealing days immediately before the shareholder meetings.

-All of the retention awards for the members of Xstrata's Executive Committee, including the three Executive Directors, will now be subject to the realisation of additional cost savings arising from the Merger.

-The previously announced EBITDA synergy estimate of at least $500 million per annum includes approximately $50 million of cost synergies.

-Vesting of retention awards for Xstrata's Management will now only occur if additional cost savings are achieved over and above the $50 million cost savings already identified in the synergy estimate.

-Merger-related cost savings will be realised from initiatives including reorganising the Combined Group's assets, the reduction of any duplicated costs not already identified in its synergy estimate, financial synergies and other cost savings.

-For the members of Xstrata's Management other than Mick Davis, Xstrata plc CEO, up to 50% of the total award will be available to vest at the first anniversary of the Effective Date.

-Shares at 1352 GMT at 789 pence, valuing the company at GBP23.6 Billion.

-Write to Mark Shapland at mark.shapland@dowjones.com

(END) Dow Jones Newswires

June 27, 2012 10:10 ET (14:10 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Pandora/ABG: Mindre sats på kursfald hos hedgefond luner aktiekursen

22-11-2017 15:47:15
Pandora har haft et hårdt 2017 på aktiemarkedet, hvilket er blevet forstærket af, at en håndfuld store investeringsselskaber har shortet aktien og dermed satset på kursfald.Derfor er det positivt for aktiekursen, at den amerikanske hedgefond Maverick Capital har mindsket sin shortposition til 0,97 pct. af aktierne fra tidligere 1,31 pct.- Det er den første større shortreduktion, vi har set gennem ..

Vestas/Sydbank: Vindmølleindustrien risikerer endnu lavere priser

22-11-2017 14:28:26
Priserne på vindmøller har været nedadgående de seneste måneder, og Vestas og de andre aktører i branchen skal ikke forvente, at det værste er overstået.Det vurderer aktieanalytiker Jacob Pedersen fra Sydbank, efter at den seneste store vindauktion i Tyskland blev afgjort med prisfald på 11 pct.- Priserne matcher meget godt den udvikling, vi har set og hørt om fra vindmølleproducenterne, så hvis m..

Novo/dir: Vækst i biofarma er afhængig af tilkøb

22-11-2017 10:07:28
Novo Nordisks ambition om at vende den negative udvikling for selskabets biofarmaforretning, så den atter kan begynde at vokse frem mod 2020, er afhængig af tre dele, herunder opkøb.Det fortalte direktør for Novos bløderdivision, Christian Kanstrup, tirsdag på Novos kapitalmarkedsdag.Salget af Novos blødermiddel Novoseven er under pres fra det konkurrerende blødermiddel Hemlimbra fra Roche, som No..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Genmab, Vestas og Pandora fortsat i fokus
2
Vestas får første russiske ordre nogensinde - NY
3
Vestas/CS: Prisudvikling og arbejdskapital koster på kursmålet - NY
4
Vestas: Ny tysk vindauktion understreger stort prispres
5
Vestas/Sydbank: Vindmølleindustrien risikerer endnu lavere priser

Relaterede aktiekurser

Glencore PLC ORD USD0.01 363,50 0,4% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. november 2017 23:07:23
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171108.1 - EUROWEB3 - 2017-11-22 23:07:23 - 2017-11-22 23:07:23 - 1 - Website: OKAY